SynerMed, the Medicaid managed service organization (MSO), has formed a joint venture company with Shanghai-based Golden Meditech Holdings, China-based integrated healthcare device and service enterprise.
According to SynerMed, the joint venture, GM-Medicare, will be China’s first health insurance information management system and business process outsourcer.
GM-Medicare has been established to optimize communication and information-sharing between insurance companies, hospitals and the insured and it will leverage SynerMed’s integrated healthcare delivery platform and leadership within the US managed care system to provide similar management solutions to the medical insurance market in China.
GM-Medicare is expected to enable medical insurance companies to offer new products and services by optimizing their information systems and business processes, while minimizing their operational costs and overall risk.
GM-Medicare also equips hospital administrators with the tools to provide sophisticated services, facilitating the growth and development of the medical insurance sector.
Aligning itself with China’s plan for medical reform, GM-Medicare will proactively implement government initiatives aimed at maximizing medical resource allocation, facilitating service innovation and research at domestic hospitals, and providing hospitals with guaranteed bill settlement.
James Mason, CEO of SynerMed, said: “By combining SynerMed’s sophisticated platform with Golden Meditech’s broad hospital network, GM-Medicare is poised to provide integrated managed care services in China, where there is an increased demand for quality, access and affordable care among a growing number of expatriate professionals and overseas tourists.
This strategic move into the world’s second-largest consumer healthcare market demonstrates SynerMed’s ability to customize and seamlessly deliver solutions on a global scale. We intend to set the standard of excellence for healthcare management in China.